Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians
- PMID: 37565377
- DOI: 10.1002/ejhf.2985
Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians
Abstract
Aims: Decongestion strategies for acute decompensated heart failure (ADHF) characterized by volume overload differ widely. The aim of this independent international academic web-based survey was to capture the therapeutic strategies that physicians use to treat ADHF and to assess differences in therapeutic approaches between cardiologists versus non-cardiologists.
Methods and results: Physicians were invited to complete a web-based questionnaire, capturing anonymized data on physicians' characteristics and treatment preferences based on a hypothetical clinical scenario of a patient hospitalized with ADHF. A total of 641 physicians from 60 countries participated. A wide variation in the management of the patient was observed. There was conservative use of diuretics, i.e. only 7% started intravenous furosemide at a dose ≥2 times the baseline oral dose, and infrequent use of ultrasound in assessing congestion (20.4%). Spot urinary sodium was infrequently or never measured by ≥85% of physicians. A third considered a patient with ongoing oedema as being stabilized. There were significant differences between cardiologists and non-cardiologists in the management of ADHF, the targets for daily body weight loss and urine output, diuretic escalation strategies (66.3% vs. 40.7% would escalate diuresis by adding a thiazide) and assessment of response to treatment (27.0% vs. 52.9% considered patients with minimal congestion as stabilized).
Conclusions: There is substantial variability amongst physicians and between cardiologists and non-cardiologists in the management of patients with ADHF, with regard to clinical parameters used to tailor treatment, treatment goals, diuretic dosing and escalation strategies.
Keywords: Acute heart failure; Diuretics.
© 2023 European Society of Cardiology.
Similar articles
-
A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure.JACC Heart Fail. 2024 Mar;12(3):508-520. doi: 10.1016/j.jchf.2023.09.029. Epub 2023 Dec 13. JACC Heart Fail. 2024. PMID: 38099890
-
The utility of urine sodium-guided diuresis during acute decompensated heart failure.Heart Fail Rev. 2024 Nov;29(6):1161-1173. doi: 10.1007/s10741-024-10424-8. Epub 2024 Aug 12. Heart Fail Rev. 2024. PMID: 39128947 Free PMC article. Review.
-
Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.Pharmacotherapy. 2016 Aug;36(8):852-60. doi: 10.1002/phar.1798. Epub 2016 Jul 29. Pharmacotherapy. 2016. PMID: 27393709
-
A Systematic Review and Meta-Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure.Pharmacotherapy. 2020 Sep;40(9):924-935. doi: 10.1002/phar.2440. Epub 2020 Aug 7. Pharmacotherapy. 2020. PMID: 32639593
-
Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.Emerg Med J. 2014 Sep;31(9):706-13. doi: 10.1136/emermed-2013-202526. Epub 2013 Jun 22. Emerg Med J. 2014. PMID: 23793945 Clinical Trial.
Cited by
-
Ultrasound imaging of congestion in heart failure: a narrative review.Cardiovasc Diagn Ther. 2025 Feb 28;15(1):233-250. doi: 10.21037/cdt-24-430. Epub 2025 Feb 25. Cardiovasc Diagn Ther. 2025. PMID: 40115103 Free PMC article. Review.
-
Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF.Circ Heart Fail. 2024 Mar;17(3):e011246. doi: 10.1161/CIRCHEARTFAILURE.123.011246. Epub 2024 Mar 4. Circ Heart Fail. 2024. PMID: 38436075 Free PMC article. Clinical Trial.
-
The assessment, interpretation and implementation of lung ultrasound examinations in Heart Failure: Current evidence and gaps in knowledge.Eur J Intern Med. 2024 Dec;130:52-61. doi: 10.1016/j.ejim.2024.09.013. Epub 2024 Oct 18. Eur J Intern Med. 2024. PMID: 39424441 Review.
-
Lower extremity lymphatic flow is associated with diuretic response in acute heart failure.Eur J Heart Fail. 2025 Jun;27(6):1136-1144. doi: 10.1002/ejhf.3655. Epub 2025 Apr 7. Eur J Heart Fail. 2025. PMID: 40194929 Free PMC article.
-
Rationale and design of the acetazolamide as a chloride sparing diuretic in patients admitted with heart failure (ADA-HF) trial.Eur Heart J Open. 2025 Mar 13;5(2):oeaf019. doi: 10.1093/ehjopen/oeaf019. eCollection 2025 Mar. Eur Heart J Open. 2025. PMID: 40134849 Free PMC article.
References
-
- Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al.; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-216. https://doi.org/10.1016/j.ahj.2004.08.005
-
- Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, et al. The use of diuretics in heart failure with congestion - A position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:137-155. https://doi.org/10.1002/ejhf.1369
-
- Kapelios CJ, Malliaras K, Kaldara E, Vakrou S, Nanas JN. Loop diuretics for chronic heart failure: A foe in disguise of a friend? Eur Heart J Cardiovasc Pharmacother. 2018;4:54-63. https://doi.org/10.1093/ehjcvp/pvx020
-
- Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J; ADHERE Scientific Advisory Committee and Investigators. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database. J Card Fail. 2007;13:422-430. https://doi.org/10.1016/j.cardfail.2007.03.011
-
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24:4-131. https://doi.org/10.1002/ejhf.2333
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical